Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
ENROLLING BY INVITATIONN/A

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

Sponsor: Intellia Therapeutics

NCT ID: NCT05697861

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 176 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
72
Started
2023-07-10
Last checked
2026-07

Plain English Summary

What is this study?

  • • Testing a new treatment for transthyretin-related (attr) familial amyloid polyneuropathy
  • • Clinical study - 72 participants
  • • This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with transthyretin-related (attr) familial amyloid polyneuropathy

Where?

  • • London - Clinical Trial Site

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.

Transthyretin-Related (ATTR) Familial Amyloid PolyneuropathyTransthyretin-Related (ATTR) Familial Amyloid CardiomyopathyWild-Type Transthyretin Cardiac Amyloidosis

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial...
  • ✓A subject has provided agreement to take part for the LTFU study.
See the full criteria
Inclusion Criteria: 1. A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received. 2. A subject has provided informed consent for the LTFU study. Exclusion Criteria: None

Where Is This Study? (1 UK site)

Clinical Trial Site

London, United Kingdom

Data sourced from ClinicalTrials.gov · Last verified: 2026-07